Objective: This study aims to assess the association of subject characteristics and NRAS mutations with HER2 expression in CRC. Methods: This research is a cross-sectional study. The research subjects in this study were colorectal cancer patients in the Digestive Surgery division at Dr. Hasan Sadikin Hospital. There were 58 study subjects. Examination of NRAS mutations was carried out by Polymerase Chain Reaction (PCR) from fresh tumour tissue obtained from surgery or colonoscopy. Meanwhile, HER2 examination used the Immunohistochemistry (IHC) method of paraffin blocks for anatomical pathology examination of the same patients. Result: HER2 overexpression was found in 6/58 (10.3%) patients with CRC, and from 8 subjects with NRAS mutations, only 1 subject (1.7%) showed overexpression of HER2. Univariate analysis of HER2 expression showed no significant associations to age, sex, histologic feature, tumor location, and NRAS mutations. A significant association was found between HER2 expression and stage of the CRC with p=0.001. Conclusion: There is no association between NRAS mutations and HER2 overexpression in colorectal cancer patients.
Adhesi peritoneum setelah pembedahan merupakan akibat dari cedera permukaan peritoneum dan iskemik jaringan. Zat anti adhesi merupakan salah satu metode menurunkan kejadian adhesi. Madu merupakan salah satu obat yang memiliki sejarah panjang sebagai anti adhesive, antibakteri, dan penyembuhan luka. Tujuan penelitian ini adalah untuk mengetahui efektivitas madu Jambi dalam pencegahan pembentukan adhesi intraabdomen. 36 tikus laki-laki jenis wistar dibagi menjadi empat kelompok. Kelompok control sebagai kelompok A, kelompok NaCl 0.9% sebagai kelompok B, kelompok Madu minimal sebagai kelompok C dan kelompok madu maksimal sebagai kelompok D, kelompok albumin minimal kelompok E dan kelompok albumin maksimal kelompok F. penilaian dilakukan pada hari ke 10 dimana data yang dikumpulkan berupa identifikasi adhesi, derajat adhesi secara makroskopis. adhesi secara makroskopis pada kelompok A sebanyak 6 tikus, kelompok B sebanyak 6 tikus, kelompok C sebanyak 2 tikus and kelompok D sebanyak 2 tikus kelompok E 5 tikus dan kelompok F 5 tikus. Perbandingan kejadian adhesi antara dua kelompok yaitu kelompok A vs C memiliki hasil bermakna (p: 0.014) dan kelompok A vs D bermakna (p: 0.014). perbandingan kelompok berdasarkan derajat adhesi memiliki hasil yang bermakna pada kelompok A vs C (P: 0.041). Madu Jambi memberikan efek anti adhesive terbaik pada luka bersih tidak terkontaminasi.
Objective: Colorectal cancer (CRC) is the world’s third most common type of cancer. Data in Indonesia based on GLOBOCAN in 2020 shows CRC in the fourth position with around 35,000 new cases each year. The pathogenesis mechanisms of CRC are complex and heterogeneous, one of which is the involvement of NRAS (Neuroblastoma Rat Sarcoma viral oncogene homolog) mutations which play a role in cell growth regulation, as well as the expression of Human epidermal growth factor receptor 2 (HER2). This study aims to assess the association of subject characteristics and NRAS mutations with HER2 expression in CRC. Methods: This research is a cross-sectional study. There were 58 patients included in this study, they were colorectal cancer patients in the Digestive Surgery division at Dr. Hassan Sadikin Hospital. Examination of NRAS mutations was carried out by Polymerase Chain Reaction (PCR) from fresh tumour tissue obtained from surgery or colonoscopy. Meanwhile, HER2 examination used the Immunohistochemistry (IHC) method of paraffin blocks for anatomical pathology examination. Result: HER2 overexpression was found in 6/58 (10.3%) patients with CRC, and from 8 subjects with NRAS mutations, only 1 subject (1.7%) showed overexpression of HER2. Univariate analysis of HER2 expression showed no significant associations to age, sex, histologic feature, tumor location, and NRAS mutations. A significant association was found between HER2 expression and stadium of the CRC with p=0.001. Conclusion: There is no association between NRAS mutations and HER2 overexpression in colorectal cancer patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.